ResearcherSecond Military Medical UniversityActive in the last 2 years
Weidong Zhang
Matched on ORCID iD 0000-0002-7384-2490; OpenAlex author ID A5100428737, A5100428749. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers · 2026: 2 papers
Papers 6
- Agrimol B induces autophagic death in TP53-mutant pancreatic cancer by targeting the S100A6-HDAC2-mutant p53 acetylation axis. Co-author DOI 10.1016/j.phymed.2026.158760↗
- Targeting CTGF+ cancer-associated fibroblasts disrupts tumor-stroma crosstalk in pancreatic ductal adenocarcinoma. Co-author DOI 10.1073/pnas.2535905123↗
- Mendelian analysis reveals novel pancreatic cancer-associated gut bacteria with tumor-suppressive effects. Co-author DOI 10.1007/s13402-025-01098-x↗
- IFN-γ-driven UBE2D3 upregulation impairs antigen presentation pathways and anti-tumor immunity in pancreatic cancer. Co-author DOI 10.1038/s41467-025-65762-4↗
- Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis. Co-author DOI 10.1186/s12943-022-01538-4↗
- Blocking CTGF-Mediated Tumor-Stroma Interplay in Pancreatic Cancer. Last author DOI 10.1016/j.molmed.2020.08.005↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xin Luan · 4 shared papers, 2020–2026 · strength 0.91
- Paper Agrimol B induces autophagic death in TP53-mutant pancreatic cancer by targeting the S100A6-HDAC2-mutant p53 acetylatio… DOI 10.1016/j.phymed.2026.158760↗
- Paper Targeting CTGF+ cancer-associated fibroblasts disrupts tumor-stroma crosstalk in pancreatic ductal adenocarcinoma. DOI 10.1073/pnas.2535905123↗
- Paper IFN-γ-driven UBE2D3 upregulation impairs antigen presentation pathways and anti-tumor immunity in pancreatic cancer. DOI 10.1038/s41467-025-65762-4↗
- Jiang‐Jiang Qin · 3 shared papers, 2022–2026 · strength 0.64
- Paper Targeting CTGF+ cancer-associated fibroblasts disrupts tumor-stroma crosstalk in pancreatic ductal adenocarcinoma. DOI 10.1073/pnas.2535905123↗
- Paper IFN-γ-driven UBE2D3 upregulation impairs antigen presentation pathways and anti-tumor immunity in pancreatic cancer. DOI 10.1038/s41467-025-65762-4↗
- Paper Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and me… DOI 10.1186/s12943-022-01538-4↗
- Shiqun Wang · 2 shared papers, 2025–2026 · strength 0.49
- Paper Targeting CTGF+ cancer-associated fibroblasts disrupts tumor-stroma crosstalk in pancreatic ductal adenocarcinoma. DOI 10.1073/pnas.2535905123↗
- Paper IFN-γ-driven UBE2D3 upregulation impairs antigen presentation pathways and anti-tumor immunity in pancreatic cancer. DOI 10.1038/s41467-025-65762-4↗
- Yiwen Shen · 2 shared papers, 2020–2026 · strength 0.42
- Yu Gan · 1 shared paper, 2025 · strength 0.30
- Hong Tu · 1 shared paper, 2025 · strength 0.30
- Yi Tong · 1 shared paper, 2025 · strength 0.30
- Rui Xu · 1 shared paper, 2026 · strength 0.26
- Wenyan Yang · 1 shared paper, 2025 · strength 0.23
- Simin Qi · 1 shared paper, 2022 · strength 0.15
- Xiaoqing Guan · 1 shared paper, 2022 · strength 0.15
- Wenjuan Yin · 1 shared paper, 2022 · strength 0.15
- Xiangdong Cheng · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.